WSFS
TEVA icon

Wilmington Savings Fund Society’s Teva Pharmaceuticals TEVA Stock Holding History

Wilmington Savings Fund Society’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.8K Hold
2,413
– – ﹤0.01% 785
2026
Q1 		$72.7K Hold
2,413
– – ﹤0.01% 804
2025
Q4 		$75.3K Hold
2,413
– – ﹤0.01% 799
2025
Q3 		$48.7K Sell
2,413
-37,160
-94% -$653K ﹤0.01% 898
2025
Q2 		$663K Buy
39,573
+3,711
+10% +$59.9K 0.01% 519
2025
Q1 		$551K Buy
35,862
+7,012
+24% +$125K 0.01% 557
2024
Q4 		$636K Buy
28,850
+26,091
+946% +$475K 0.01% 524
2024
Q3 		$49.7K Buy
+2,759
New +$48.3K ﹤0.01% 1222
2016
Q4 		– Sell
-8,890
Closed -$409K – 334
2016
Q3 		$409K Buy
8,890
+225
+3% +$11.7K 0.03% 250
2016
Q2 		$435K Buy
8,665
+2,989
+53% +$159K 0.03% 248
2016
Q1 		$303K Sell
5,676
-249
-4% -$14.6K 0.02% 273
2015
Q4 		$389K Buy
5,925
+300
+5% +$18.5K 0.02% 260
2015
Q3 		$317K Hold
5,625
– – 0.02% 271
2015
Q2 		$333K Buy
5,625
+535
+11% +$33K 0.02% 281
2015
Q1 		$317K Sell
5,090
-1,693
-25% -$98.4K 0.02% 284
2014
Q4 		$390K Sell
6,783
-475
-7% -$26.5K 0.02% 277
2014
Q3 		$390K Hold
7,258
– – 0.02% 280
2014
Q2 		$380K Sell
7,258
-1,015
-12% -$51.9K 0.02% 298
2014
Q1 		$438K Buy
8,273
+2,748
+50% +$127K 0.02% 286
2013
Q4 		$221K Sell
5,525
-4,567
-45% -$180K 0.01% 357
2013
Q3 		$381K Buy
10,092
+590
+6% +$23K 0.02% 294
2013
Q2 		$372K Buy
+9,502
New +$370K 0.02% 291

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wilmington Savings Fund Society's TEVA Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 2,413 shares worth $81.8K. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Wilmington Savings Fund Society first reported a position in TEVA in Q2 2013 and has held it in 22 quarters since. The position peaked at $663K in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Wilmington Savings Fund Society held 2,413 shares of Teva Pharmaceuticals worth $81.8K as of Q2 2026.
  • Wilmington Savings Fund Society left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #785 holding.
  • Wilmington Savings Fund Society first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
  • Wilmington Savings Fund Society's Teva Pharmaceuticals position peaked at $663K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.